Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895583 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 254
- Enrollment target
NCT00895583: Completed Phase 4 study, sponsored by Pfizer.
NCT00895583 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 254 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00895583, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 254 participants
- Enrollment target
Study Summary
This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.
Primary Outcome
GFR was calculated using the Modified Diet in Renal Disease (MDRD) equation using either serum creatinine traceable to isotope dilution mass spectrometry (IDMS) or serum creatinine not traceable to IDMS.
Interventions
- DRUG Sirolimus
- DRUG Tacrolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
What the finished NCT00895583 record still lists
NCT00895583 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 2 interventions - of which Sirolimus is the first listed.
NCT00895583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00895583 about?
NCT00895583 is a clinical study titled "Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients". This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.
What is the current status of trial NCT00895583?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 254 participants. The study started on 2009-06. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00895583?
The interventions under investigation include: Sirolimus (DRUG), Tacrolimus (DRUG).
Who is sponsoring clinical trial NCT00895583?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00895583's enrollment target sits among peer trials
254 337th of 2000 higher than 1,662 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia